World CNS Summit 2017

Pre-Conference Workshop Day of World CNS Summit 2017 (Boston, 20th of February, 2017) Paves the Basis of a Roadmap for an Alliance among Trans-Continental Pre-Competitive Public-Private Entities Leveraging Open Science to Develop Effective Biomarkers for Use in Drug Development against Alzheimer’s disease

  • The Pre-Conference Workshop Day of the World CNS Summit 2017 (Boston, 20th of February, 2017) aimed at discussing the basis of a roadmap to improve the cooperation for joint calls and shared protocols, placebo databases, analysis tools, and other resources among pre-competitive European and USA Public-Private entities leveraging open science for the discovery of novel targets and development of effective biomarkers for use in drug development against Alzheimer’s disease (AD). These entities comprise the European Innovative Medicine Initiative (IMI) as well as important stakeholders based in the USA such as the National Institute on Aging (NIA) and National Institute of Health (NIH), Coalition Against Major Diseases (CAMD) of the Critical Path Institute (C-Path), the Accelerating Medicines Partnership - Alzheimer’s Disease (AMP-AD), and the Global Alzheimer’s Platform Foundation (GAP-NET).
  • The Workshop was chaired by Dr. Claudio Babiloni (University of Rome “La Sapienza”), and the invited speakers were Dr. Samuel Agus (H. Lundbeck A/S), Dr. Andrew Satlin (Eisai, IMI-EPAD), Dr. Suzana Petanceska (NIA/NIH, AMP-AD), Dr. Stephen P Arnerić (CAMD/C-Path), and Dr. Richard Mohs (GAP-NET). The chairman depicted the enormous social burden of AD due to the lack of a disease-modifying therapy despite hundreds of clinical studies. The need for a global alliance against AD emerged from these repeated failures. The invited speakers laid out their view on the challenges that exist within the environment from the perspective of various stakeholders. Speakers who represented the global Private-Public-Partnerships (namely: IMI-EPAD, AMP-PD, CAMD/C-Path and GAT-NET) also described how their organizations aim to target these challenges. The general discussion emphasized the unique enriching value of any organization and the great potential of future coordinated actions of common interest sharing expertise and research outcomes. 
  • The chairman and the invited speakers agreed to write an article exploiting the intense discussion of the Day towards a roadmap for the foundation of a transcontinental Europe-USA wide platform on AD grounded on a solid alliance among IMI, CAMD/C-Path, NIA/NIH, AMP-AD, and GAP-NET.

Boston, February the 20th 2017

Participants
Italiano
Lunedì, 13 Marzo, 2017

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma